3rd Quarter - Report

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$218,013
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

The 340B Drug Pricing Program; H.R. 5376 - The Inflation Reduction Act; H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; S.4659 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Support for Congressional letter to HHS calling on the department to take enforcement actions against noncompliant drug companies.

LobbyistCovered position, as disclosed
GREG DOGGETT —
THOMAS ALFRED O'DONNELL New Staff to members of the U.S. House of Representatives: Rep. Pat Schroeder, Rep. Lane Evans, Rep. Rush Holt, Rep. Phil Hare, Rep Steve Rothman. Professional Staff member on the House Committee on Veterans Affairs.
AMANDA SELLERS SMITH —
MAUREEN TESTONI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Bills named: S. 4659 (117th), H.R. 5376 (117th), H.R. 8295 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.